RO-7449135

N/A

Report date: 2023/10/13 15:55:51

Base Information

Drug NameRO-7449135

Drug Alias NameRO7449135RO-7449135

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Kallikrein-5Anti-Kallikrein-7

TargetsKallikrein-5Kallikrein-7

Therapy Area/IndicationsNetherton Syndrome

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGenentech Inc

China Registration ClassN/A

Develop Information

Active CompaniesGenentech Inc

Inactive CompaniesN/A

Active IndicationsNetherton Syndrome

Inactive IndicationsN/A

Other Information

ATC CodeN/A